I det här avsnittet möter vi Dr. Emad som delar sina erfarenheter och berättar bland annat om vad som inspirerade honom till att välja medicinsk retina som sitt specialistområde.

Host: Shahin Aeinehband

Medverkande: Imadeddin Abu Ishkheidem

/Eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

Frågor eller synpunkter?

eyepod@bayer.com 

MA-M_AFL-DK-0198-1 

Hosted on Acast. See acast.com/privacy for more information.

Today we are presenting another Viewpoint from the Vision academy.

The title of the Viewpoint is: Coordinated Care in Diabetic Eye Disease Management

We would be happy to hear your feedback.

eyepod@bayer.com

MA-M_AFL-DK-0177-1

Hosted on Acast. See acast.com/privacy for more information.

Det här är en förkortad återsändning av avsnitt 8 från 2019, där vi  intervjuade Tord Jonsson. Tord är pensionerad läkare och har själv AMD.

I den längre versionen diskuterade vi också det svenska makularegistret och hur registret kan användas av patienter.

Den ursprungliga intervjun:

https://open.spotify.com/episode/12X6w5XSVB6bJrwxZVfzQS

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

All viewpoints can be found at www.visionacademy.org/resources

EyePod@Bayer.com

MA-M_AFL-DK-0176-1

Hosted on Acast. See acast.com/privacy for more information.

In the upcoming episodes we will focus on Viewpoints from the Vision Academy. The Vision Academy is a partnership between Bayer and ophthalmic specialists, established with the aim of addressing key clinical challenges in the field of retinal diseases.
Today we are presenting the viewpoint: Bilateral Anti-VEGF treatment and I have my colleague and medical advisor Haleh Davanian with me.

EyePod@Bayer.com

MA-M_AFL-DK-0175-1

Hosted on Acast. See acast.com/privacy for more information.

EyePod@Bayer.com

MA-M_AFL-DK-0173-1

Hosted on Acast. See acast.com/privacy for more information.

The following two episodes, where we have Memira Eyecenter as our guest, will be focusing on refractive surgery, including laser techniques and refractive lens extraction, and we have the honor to welcome Dr Johan Germundsson as our expert and distinguished guest for this session.

Enjoy!

EyePod@Bayer.com

Hosted on Acast. See acast.com/privacy for more information.

Enjoy and please let us know your thoughts of this episode

EyePod@Bayer.com

Hosted on Acast. See acast.com/privacy for more information.

This is the first part of two. In the second part we will discuss uveal tumors.

Enjoy and please let us know your thoughts of this episode

EyePod@Bayer.com

MA-M_AFL-DK-0150-1

Hosted on Acast. See acast.com/privacy for more information.

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

Enjoy this follow-up episode with Dr Mario Economou.

Let us hear your thoughts!

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

Here in this first part, we talk about medical glaucoma together with Dr Mario Economou. The second part will be about surgical glaucoma.

Enjoy and let us hear your thoughts!

eyepod@bayer.com

MA-M_AFL-DK-0095-1

Hosted on Acast. See acast.com/privacy for more information.

This is the second episode with Dr Eva Olofsson from Umeå University Hospital. The following episode will be focusing on macular surgery - specifically macular hole and pucker.

Welcome to listen!

eyepod@bayer.com

MA-M_AFL-DK-0094-1

Hosted on Acast. See acast.com/privacy for more information.

In the following episode we will be focusing on endophthalmitis, and we have the honor to welcome Dr Eva Olofsson from Umeå University Hospital, a vitreoretinal surgeon, and the chairman of the Swedish Society of Ophthalmology, as our expert and distinguished guest for this session.

Did you like the interview? Let us know your thoughts!

eyepod@bayer.com

MA-M_AFL-DK-0093-1

Hosted on Acast. See acast.com/privacy for more information.

The following episode will be focusing on handling of non-infectious-uveitis patients, and we have the honor to welcome Dr Avinash Gurbaxani from Moorfields Eye Hospital Dubai as our expert and distinguished guest for this session.

Welcome! 

eyepod@bayer.com

MA-M_AFL-DK-0086-1

Hosted on Acast. See acast.com/privacy for more information.

In this special episode, you will hear more about congenital aniridia, a rare but devastating pan-ocular disease resulting from mutations in the PAX6 gene.

To bring together the various existing efforts to understand, manage, and treat aniridia, ANIRIDIA-NET was established. Stay tuned to hear more about it!

Appearing in this podcast:

Prof. Neil Lagali
Prof. Dominique Bremond-Gignac
Juliana Martinez
Ivana Kildsgaard

Questions?

eyepod@bayer.com

MA-M_AFL-DK-0071-2

Hosted on Acast. See acast.com/privacy for more information.

In this episode, we talk about stem cells with prof Tor Paaske Utheim! 

eyepod@bayer.com

MA-M_AFL-DK-0079-1

Hosted on Acast. See acast.com/privacy for more information.

In this episode, we talk about dry eye disease.

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

In this episode we talk about Sars-Cov-2 effects on the vessels.

Enjoy!

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Here, we give you a short summary including some segments from the meeting.

-Treatment regimens in nAMD with prof Jean-Francois Korobelnik
-Imaging in nAMD and RVO with prof Giovanni Staurenghi
-Exit treatment in nAMD patients with prof Justus Garweg and Dr Stamatios Aslanis
-Introduction to RVO with Dr Elin Gunnlaugsdottir
-Health Economy and Quality of Life with prof Hannu Uusitalu

Let us know if you liked this summary by sending us an e-mail.

If you are from Scandinavia, let us know if you want the recordings.

eyepod@bayer.com

MA-M_AFL-DK-0061-1

Hosted on Acast. See acast.com/privacy for more information.

Today we have the honor and pleasure to welcome back Jakob Grauslund, Clinical Professor and Consultant at the Research Unit of Ophthalmology at the University in Odense. Jakob is going to share with us his experiences and expertise as a clinician and researcher in diabetes, and especially how OCT-A can be used as a tool in the management of diabetic retinopathy.

This is the third part where we will continue to talk about OCT-A in Diabetic Retinopathy!

Did you like this episode? Let us know your thoughts!

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

Today we have the honor and pleasure to welcome back Jakob Grauslund, Clinical Professor and Consultant at the Research Unit of Ophthalmology at the University in Odense. Jakob is going to share with us his experiences and expertise as a clinician and researcher in diabetes, and especially how OCT-A can be used as a tool in the management of diabetic retinopathy.

Stay tuned for the third part where we will continue to talk about OCT-A in Diabetic Retinopathy!

Did you like this episode? Let us know your thoughts!

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

In this episode, our moderators professor Michael Larsen and Dr Elin Gunnlaugsdottir gives us all their reasons to why you should register to attend the virtual Nordic Retina Meeting 2021, which will be on 4-5th of February 2021, with both Nordic and international speakers. 

This is an reminder, to those of you in the Nordic countries who have already received an invitation, to register.

Link to agenda and registration (agenda at the bottom):

lyyti.fi/reg/Bayer_4546/se

or e-mail to

eyepod@bayer.com

MA-M_AFL-DK-0025-1

Hosted on Acast. See acast.com/privacy for more information.

Today we have the honor and pleasure to welcome back Jakob Grauslund, Clinical Professor and Consultant at the Research Unit of Ophthalmology at the University in Odense. Jakob is going to share with us his experiences and expertise as a clinician and researcher in diabetes, and especially how OCT or OCT-angiography can be used as a tool in the management of diabetic retinopathy.

In this first part, we will focus on OCT. Stay tuned for the second part where we talk about OCT-A in Diabetic Retinopathy!

Did you like this episode? Let us know your thoughts!

eyepod@bayer.com

MA-M_AFL-DK-0036-1

Hosted on Acast. See acast.com/privacy for more information.

In the previous parts of this series, we talked about the anterior segment, and now we are going to continue with imaging of the back of the eye and retina with OCT and OCT-A , beginning with wet AMD.

This is the third part of the interview with Neil and Stamatis, where we talk about OCT-A in clinical practice with focus on wet AMD. 
In the next interviews, we will talk about OCT and OCT-A in Diabetic Retinopathy, stay tuned! 

Enjoy!

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

In the previous parts of this series, we talked about the anterior segment, and now we are going to continue with imaging of the back of the eye and retina with OCT and OCT-A , beginning with wet AMD.

This is the second part of the interview with Neil and Stamatis, where we talk about OCT in clinical practice with focus on wet AMD. In the next part, we will talk about OCT-A, stay tuned! 

Enjoy!

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

In the previous parts of this series, we talked about the anterior segment, and now we are going to continue with imaging of the back of the eye and retina with OCT and OCT-A , beginning with wet AMD.

This is the first part of the interview with Neil and Stamatis, where we talk about OCT in general. In the next part, we will talk about OCT in nAMD. 

Enjoy!

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

In this episode, our moderators professor Michael Larsen and Dr Elin Gunnlaugsdottir gives us all their reasons to why you should register to attend the virtual Nordic Retina Meeting 2021, which will be on 4-5th of February 2021, with both Nordic and international speakers. 

This is an reminder, to those of you in the Nordic countries who have already received an invitation, to register.

Link to agenda and registration (agenda at the bottom):

lyyti.fi/reg/Bayer_4546/se

or e-mail to

eyepod@bayer.com

MA-M_AFL-DK-0025

Hosted on Acast. See acast.com/privacy for more information.

In the future episodes in the imaging series, we will talk about OCT and OCT-A in wet AMD, followed by Diabetic Retinopathy. Stay tuned! 

eyepod@bayer.com

MA-M_AFL-DK-0021-1

Hosted on Acast. See acast.com/privacy for more information.

This episode will focus on how we can apply confocal imaging technique in the clinic - When to use it and how to interpret the outcome of the examination.

Enjoy!

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

This exciting episode will be the first in a series of interesting interviews and discussions about imaging of the eye. We will start in the anterior part, with confocal microscopy of the cornea, and continue with imaging of the back of the eye and retina with OCT and OCT-A.
With us today we have Neil Lagali, from the Institution for Biomedical and Clinical Sciences at Linköping University. 
Neil is professor and internationally recognized expert in confocal microscopy. This is his second visit to the EyePod and last time he shared his knowledge in angiogenesis in the eye. Today we are looking forward to discussing the background and technical aspects of confocal microscopy of the cornea. In a second episode, we will invite Dr Berit Byström, assistant professor and consultant at the Eye Department at Umeå University, to discuss the clinical application with this interesting imaging technique.     

eyepod@bayer.com

MA-M_AFL-DK-0018

Hosted on Acast. See acast.com/privacy for more information.

Register: eyepod@bayer.com or https://www.lyyti.fi/reg/VAWebinar

This is a revisit of our previously published episode “What is Vision Academy”.

• On November 3rd 2020, Bayer Scandinavia is hosting an online meeting together with Vision Academy, with the topic Addressing Clinical Challenges In Ophthalmology. 
• The webinar will include two live debates on key clinical challenges in ophthalmology and is chaired by Professor Anat Loewenstein of Tel Aviv University.
• Topics will be debated by Vision Academy members Dr. David Wong of the University of Toronto and Dr. Monica Lövestam-Adrian of Lund University.
• You will be able to participate in the Q&A session

This is a meeting for health care professionals in our Nordic and Baltic countries, who have already received an invitation. If you who have been invited would like to register to the meeting, please send an e-mail to eyepod@bayer.com or follow the link below

https://www.lyyti.fi/reg/VAWebinar

Thank you!

Hosted on Acast. See acast.com/privacy for more information.

In this episode, we are talking about EURETINA 2020 together with Dr Pierfrancesco Mirabelli from Linköping University Hospital.

Comments?

eyepod@bayer.com

MA-M_AFL-DK-0014-1

Hosted on Acast. See acast.com/privacy for more information.

In todays episode, we are talking with Tomer Feffer, CEO of Bayer Scandinavia and Anders Blanck, Administrative Director, LIF (The research-based pharmaceutical industry / Läkemedelsföretagens Intresseförening).

Let us know your thoughts!

eyepod@bayer.com  

MA-EYL-DK-0142-1

Hosted on Acast. See acast.com/privacy for more information.

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

I detta avsnitt har vi bjudit in fysioterapeut och ergonom Märta Remneblad från Linköping som ger oss tips om hur vi ska arbeta för att undvika förslitningsskador. 

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

Today we have the honor to welcome Ann Hellström, Professor in Pediatric Ophthalmology at the Institute of Neuroscience and Physiology at The Queen Silvia Children’s Hospital, Gothenburg, Sweden. She will share with us her experiences and expertise as a clinician and researcher in Retinopathy of Prematurity also known as ROP.

Did you like this interview? Looking forward to hear your thoughts!

eyepod@bayer.com

MA-EYL-DK-0135

Hosted on Acast. See acast.com/privacy for more information.

Today we have the honor to welcome Ann Hellström, Professor in Pediatric Ophthalmology at the Institute of Neuroscience and Physiology at The Queen Silvia Children’s Hospital, Gothenburg, Sweden. She will share with us her experiences and expertise as a clinician and researcher in Retinopathy of Prematurity also known as ROP.

Did you like this interview? Looking forward to hear your thoughts!

eyepod@bayer.com

MA-EYL-DK-0134

Hosted on Acast. See acast.com/privacy for more information.

Today we have the honor to welcome Ann Hellström, Professor in Pediatric Ophthalmology at the Institute of Neuroscience and Physiology at The Queen Silvia Children’s Hospital, Gothenburg, Sweden. She will share with us her experiences and expertise as a clinician and researcher in Retinopathy of Prematurity also known as ROP.

Did you like this interview? Looking forward to hear your thoughts!

eyepod@bayer.com

MA-EYL-DK-0133

Hosted on Acast. See acast.com/privacy for more information.

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

In this episode, we are honored to have Professor Paolo Lanzetta, Founder and Scientific Director at European Institute for ocular microsurgery in Udine. Dr Lanzetta is one of the members in the Vision Academy Steering Committee and will share his insights of the guidelines and give us an update from the situation in Italy.

In our discussions, we refer to the recently published paper in Graefe's Archive for Clinical and Experimental Ophthalmology: Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic. This paper was authored by the network Vision Academy, sponsored by Bayer, which is an international group of retinal experts who collaborate to share existing skills and knowledge in retinal diseases.

Let us know your thoughts by sending an e-mail! 

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

Today we are going to discuss how the current situation can affect treatment of patients with intravitreal injections and we will refer to a recently published paper in Graefe's Archive for Clinical and Experimental Ophthalmology: Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic. This paper was authored by the network Vision Academy, sponsored by Bayer, which is an international group of retinal experts who collaborate to share existing skills and knowledge in retinal diseases.

The recommendations published in the paper were developed during a virtual meeting in March 2020 by the 14-member-Vision Academy Steering Committee. Already available guidance documents for patients receiving intravitreal injections of anti-VEGF agents during the COVID-19 pandemic were reviewed, debated and summarized in the paper. In only 18 days the manuscript was finalized, submitted and accepted for publication, which probably makes it one of the fastest publications in history!

In this episode, we are honored to have Monica Lövestam-Adrian, Head of the Medical Retina Department at Lund University Hospital and Associate Professor in Ophthalmology at Lund University in Sweden. Monica is one of the members in the Vision Academy Steering Committee and will share her insights of the guidelines with us today. 

For contact:
eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

Det här avsnittet spelar vi in med anledning av Covid-19 pandemin.
Vi blir alla påverkade på ett eller annat sätt vilket kan leda till oro i samhället, framför allt när vi inte vet hur länge det kommer att pågå. Därför känner vi att det skulle vara värdefullt att få råd om hur man kan förhålla sig till de nya omständigheterna. Med oss idag har vi därför Åsa Kadowaki, legitimerad psykiatriker och legitimerad psykoterapeut.
Dagens intervju görs av Beatrice Peebo medicinsk rådgivare på Bayer.

Låt oss veta vad du tyckte!

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

Frågor och synpunkter är välkomna!

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

Som vår gäst idag har vi äran att välkomna docent Marita Andersson Grönlund vid Sahlgrenska universitetssjuhuset. Vårt samtal idag handlar om barnuveiter med särskilt fokus på JIA-relaterad irit (JIA - Juvenile idiopathic arthritis), och i ett andra avsnitt om Cortical Visual Impairment (CVI). Marita Grönlund är en av våra ledande experter på området i Sverige och vi är mycket glada och tacksamma för denna intervju där hon delar sina kunskaper och erfarenheter inom barnoftalmologi.

Välkomna att lyssna och berätta gärna vad ni tycker med ett kort mail, tack!

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

Som vår gäst idag har vi äran att välkomna docent Marita Andersson Grönlund vid Sahlgrenska universitetssjuhuset. Vårt samtal idag handlar om barnuveiter med särskilt fokus på JIA-relaterad irit (JIA - Juvenile idiopathic arthritis), och i ett andra avsnitt om Cortical Visual Impairment (CVI). Marita Grönlund är en av våra ledande experter på området i Sverige och vi är mycket glada och tacksamma för denna intervju där hon delar sina kunskaper och erfarenheter inom barnoftalmologi.

Välkomna att lyssna och berätta gärna vad ni tycker med ett kort mail, tack!

eyepod@bayer.com

MA-EYL-DK-0113-1

Hosted on Acast. See acast.com/privacy for more information.

Today we will discuss an important topic for many of our patients and those of you active within the Ophthalmological Society – namely the Swedish Cataract Register which started in 1992 and is highly recognized and well known within as well as outside the Swedish borders.  

The primary aim of the register was to assess waiting time for cataract surgery and BCVA at the time for surgery and has evolved to include outcome of visual function, quality data and incidence of endophthalmitis.  So far the register has contributed to numerous publications with important and helpful outcomes and guidance, valuable both for patients and for cataract surgeons all over the world.

It is with honor and joy we welcome today Professor Anders Behndig, currently responsible for the cataract register and Professor Mats Lundström, founder of the register.

Welcome!

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

https://sv.surveymonkey.com/r/ZRVM3SR

English (takes about 1 min):

https://sv.surveymonkey.com/r/N7B7RNR

Tack!

EyePod@bayer.com

 MA-EYL-DK-0108-1

Hosted on Acast. See acast.com/privacy for more information.

Today we will discuss an important topic for many of our patients and those of you active within the Ophthalmological Society – namely the Swedish Cataract Register which started in 1992 and is highly recognized and well known within as well as outside the Swedish borders.  

The primary aim of the register was to assess waiting time for cataract surgery and BCVA at the time for surgery and has evolved to include outcome of visual function, quality data and incidence of endophthalmitis.  So far the register has contributed to numerous publications with important and helpful outcomes and guidance, valuable both for patients and for cataract surgeons all over the world.

It is with honor and joy we welcome today Professor Anders Behndig, currently responsible for the cataract register and Professor Mats Lundström, founder of the register.

Welcome!

eyepod@bayer.com

MA-EYL-DK-0104-1

Hosted on Acast. See acast.com/privacy for more information.

I detta avsnitt pratar vi med Sten Kjellström om ledarskap och vad man kan tänka på för att bli en bra ledare.

Välkomna!

eyepod@bayer.com

MA-EYL-DK-0103-1

Hosted on Acast. See acast.com/privacy for more information.

Denna gång hör vi korta intervjuer från deltagare på MRK 2019.

Välkomna att lyssna!

eyepod@bayer.com

MA-EYL-DK-0102-1

Hosted on Acast. See acast.com/privacy for more information.

In this episode, we interview some of our speakers on the evenening meeting in Copenhagen the 5th of December.

Professor Justus Garweg from Bern in Switzerland speaks about pros and cons of long term treatment with anti-VEGF.

Anna Stage Vergmann from Odense Universitetshospital speaks about OCT-A as a new way of assessing neovascularizations in proliferative diabetic retinopathy.

Mads Forslund Jacobsen from Rigshospitalet/Glostrup speaks about Robot-assisted vitreoretinal surgery.

Welcome!

eyepod@bayer.com

MA-EYL-DK-0101-1

Hosted on Acast. See acast.com/privacy for more information.

Om ni har frågor eller vill berätta vad ni tyckte om avsnittet, maila!

Eyepod@bayer.com

MA-EYL-DK-0099-1

Hosted on Acast. See acast.com/privacy for more information.

Om ni har frågor eller vill berätta vad ni tyckte om avsnittet, maila!

Eyepod@bayer.com

MA-EYL-DK-0098-1

Hosted on Acast. See acast.com/privacy for more information.

This time, we had the honor to interview Professor Michael Larsen on Diabetic Retinopathy.
This is the second part where Dr. Larsen talks about treatment of Diabetic Retinopathy.

Don't forget to subscribe for future episodes.

Let us know your thoughts!

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

This time, we had the honor to interview Professor Michael Larsen on Diabetic Retinopathy.
In this first part, Dr Larsen gives us a short review from the past to the present to the future.
In the second part, we discuss treatment. Don't forget to subscribe for future episodes.

Let us know your thoughts!

eyepod@bayer.com

MA-EYL-DK-0086-1

Hosted on Acast. See acast.com/privacy for more information.

Diabetes is the epidemic of the 21st century. The western lifestyle gives you high risk of becoming obese and getting diabetes. Diabetic retinopathy is by far the most common complication of diabetes and end-stage complications include proliferative diabetic retinopathy (PDR) and diabetic macular edema (DME), both induced by hyperglycemia.

This is the third and last episode in this series, together with Professor Jakob Grauslund from Odense, Denmark, where we discuss treament.

In the coming weeks, we will hear Professor Michael Larsens thoughts on the same topic so make sure you subscribe to not miss future episodes.

Welcome to let us know your thoughts by writing to:

eyepod@bayer.com

Thank you!

Hosted on Acast. See acast.com/privacy for more information.

Diabetes is the epidemic of the 21st century. The western lifestyle gives you high risk of becoming obese and getting diabetes. Diabetic retinopathy is by far the most common complication of diabetes and end-stage complications include proliferative diabetic retinopathy (PDR) and diabetic macular edema (DME), both induced by hyperglycemia.

This is the second episode of three together with Professor Jakob Grauslund from Odense, Denmark, where we discuss screening for diabetic retinopathy and how technology in the form of artificial intelligence can contribute to a better healthcare.

Welcome to listen and let us know your thoughts by writing to us at:

 eyepod@bayer.com

Thank you!

Hosted on Acast. See acast.com/privacy for more information.

Diabetes is the epidemic of the 21st century. The western lifestyle gives you high risk of becoming obese and getting diabetes. Diabetic retinopathy is by far the most common complication of diabetes and end-stage complications include proliferative diabetic retinopathy (PDR) and diabetic macular edema (DME), both induced by hyperglycemia.

This is the first episode of three together with Professor Jakob Grauslund from Odense, Denmark, where we discuss diabetes in general, pathogenesis of DR, genetic associations and epidemiology.

Welcome to listen and let us know if you liked it by writing to us at:

 eyepod@bayer.com

Thank you!

MA-EYL-DK-0081-1

Hosted on Acast. See acast.com/privacy for more information.

Det finns undersökningar hos allmänheten som visar att rädsla för synnedsättning är i paritet med rädsla för att drabbas av cancer eller demens. Men slår det synsättet igenom i vår sjukvård idag? Är patienten i fokus när våra folkvalda politiker och företrädare för hälso- och sjukvården gör sina prioriteringar?

Hör debatten från Almedalen! Vill du istället se en video från seminariet?

https://www.youtube.com/watch?v=qZ8r6QMRn4E

Berätta vad du tyckte!

eyepod@bayer.com

MA-EYL-DK-0080-1

Hosted on Acast. See acast.com/privacy for more information.

In this episode, we hear short interviews with Drs who attended Euretina 2019.

Let us know your thoughts!

eyepod@bayer.com

MA-EYL-DK-0067-1
MA-EYL-DK-0065-1
MA-EYL-DK-0077-1

Hosted on Acast. See acast.com/privacy for more information.

In this episode, Roza Ghotbi, Scientific Advisor at Bayer Scandinavia, provide a brief summary with the highlights from Euretina 2019.

Also, make sure you hear our interviews with Dr Korobelnik, Dr Rafiq Hasan, Global Head of Bayer Ophthalmology and upcoming episodes from Euretina.

We would be happy to have your comment.

eyepod@bayer.com

MA-EYL-DK-0076-1

Hosted on Acast. See acast.com/privacy for more information.

In this episode we speak with Dr Rafiq Hasan, Global Head of Ophthalmology at Bayer.

Let us know your thoughts by writing to us!

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

In this episode, we are at Euretina 2019 and here we speak with Dr Korobelnik who elaborates on the topic of imaging.

eyepod@bayer.com

 MA-EYL-DK-0066

Hosted on Acast. See acast.com/privacy for more information.

In this short episode Professor Jakob Grauslund from Odense, Denmark talks about deep learning, OCT-A among his other take home messages from ARVO 2019 in Vancouver.

Enjoy!

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

I detta avsnitt befinner vi oss på ARVO 2019 i Vancouver och vi diskuterar intryck från kongressen tillsammans med Dr Sten Kjellström som är disputerad läkare och verksamhetschef i Skåne.
Vi pratar bland annat om genterapi, artificiell intelligens och mycket mer. Sten berättar också om vad man kan tänka på för att få ut så mycket som möjligt när man går på kongresser.

Välkomna att skriva till oss om ni gillade avsnittet eller om ni har förslag på samtalsämnen.

EyePod@bayer.com

MA-M_AFL-DK-0096-1

Hosted on Acast. See acast.com/privacy for more information.

I detta avsnitt befinner vi oss på ARVO 2019 i Vancouver där vi träffar Dr Maria Bitziou och Dr Martin Breimer från Sahlgrenska Universitetssjukhuset. Maria och Martin presenterar en poster som handlar om deras journalsystemet för patienter med diabetes retinopati. Fördelen med journalsystemet är att det effektiviserar och sparar resurser. Vidare ger de tips på hur man gör en bra poster inför stora kongresser. Välkomna att lyssna!

EyePod@bayer.com

MA-M_AFL-DK-0085-1

Hosted on Acast. See acast.com/privacy for more information.

Här pratar vi med Dr Sten Kjellström direkt efter seminariet Får den som lever se, på Almedalen 2019. Seminariet handlade om prioriteringar inom vården.

Under hösten kommer höjdpunkterna från själva seminariet, tillsammans med hela panelen.

Vid frågor eller synpunkter kan man skriva till

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

Thank you for listening!

EyePod@Bayer.com

Hosted on Acast. See acast.com/privacy for more information.

In this episode, we will hear Dr George Lambrou and Professor Anat Loewenstein explain what Vision Academy is and how the network can help you in your daily clinical practice.

Please feel free to provide questions or feedback to:

eyepod@bayer.com

Enjoy!

MA-EYL-NO-0013-1

Hosted on Acast. See acast.com/privacy for more information.

I de två senaste avsnitten har vi diskuterat det svenska makularegistret och hur man som läkare kan utnyttja de nya funktionerna.

I denna del fokuserar vi på hur det Svenska Makularegistret kan användas ur ett patientperspektiv (och mycket mer). Vi intervjuar Tord Jonsson, som är ögonläkare och sedan en tid tillbaka även patient med "gula fläcken", vilket också förkortas AMD.

Välkomna att lyssna på Tord Jonsson och hans berättelse om hur han först märkte att han hade sjukdomen.

Kommentera gärna på:

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

eyepod@bayer.com

MA-EYL-DK-0057-1

Hosted on Acast. See acast.com/privacy for more information.

eyepod@bayer.com

MA-EYL-DK-0056-1

Hosted on Acast. See acast.com/privacy for more information.

I detta avsnitt sammanfattas den andra dagen som handlade om diabetes makulaödem (DME).
Vi hör också Prof. Catherine Creuzot-Garcher från Frankrike, Prof. Giovanni Staurenghi från Italien och Prof. Jakob Grauslund från Danmark sammanfatta sina budskap från mötet.

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

I detta avsnitt sammanfattas den första dagen som handlade om våt Åldersrelaterad Makuladegeneration. Vi hör också Dr Patricia Udaondo från Spanien och professor Morten Moe från Norge sammanfatta sina budskap från mötet, samt kommentarer från deltagande läkare.

eyepod@bayer.com

MA-EYL-SE-0056-1

Hosted on Acast. See acast.com/privacy for more information.

eyepod@bayer.com

MA-M_AFL-DK-0069-1

Hosted on Acast. See acast.com/privacy for more information.

eyepod@bayer.com

MA-EYL-SE-0054-1

Hosted on Acast. See acast.com/privacy for more information.

eyepod@bayer.com

MA-EYL-SE-0053-1

Hosted on Acast. See acast.com/privacy for more information.

eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.

Varmt välkomna att lyssna!

Hosted on Acast. See acast.com/privacy for more information.

Vid frågor eller synpunkter eyepod@bayer.com

/Bayer Oftalmologi

MA-PFM-OPHT-SE-0002-1

Hosted on Acast. See acast.com/privacy for more information.

Vid frågor, synpunkter eller förslag på samtalsämnen är ni välkomna att skriva till oss på eyepod@bayer.com

Hosted on Acast. See acast.com/privacy for more information.